Assessing ultrasound abnormalities in gout patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the prevalence and severity of ultrasound-detected inflammatory, structural, and deposit lesions in patients diagnosed with gout. Conducted at the Ambroise Paré Hospital, the study includes adult patients who meet the ACR/EULAR 2015 criteria for gout and are able to provide informed consent. Participants will undergo clinical and ultrasound examinations performed by two independent physicians to ensure unbiased results. The findings will help establish a clearer understanding of the impact of gout on joints and tendons.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Inclusion criteria were adult patients with a diagnosis of gout according to ACR/EULAR 2015 criteria and able to give informed consent. Exclusion criteria were the presence of other chronic inflammatory rheumatic diseases and patients without French social insurance.

Exclusion Criteria:

\-

Where it's running

• Rhumatology department, Ambroise Paré hospital - APHP
  Boulogne-Billancourt, Aphp, France Recruiting

Study contacts

• Principal investigator: Maria-Antonietta D'AGOSTINO, MD, PhD — Rhumatology department, Ambroise Paré hospital - APHP
• Study coordinator: Maria-Antonietta D'AGOSTINO, MD, PhD
• Email: maria-antonietta.dagostino@aphp.fr
• Phone: +33 01 49 09 56 74

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Dotinurad in gout patients who can’t tolerate XOI or failed uricase treatment

  This trial tests whether dotinurad can lower uric acid levels in adults with gout who can’t use certain standard medicines or have not benefited from uricase.

  Recruiting at 41 sites Phase 2 Crystalys Therapeutics · Birmingham, Alabama and 40 other locations · NCT07535034

• Orienting project on crystal deposits in gout, CPPD, and osteoarthritis

  This project will follow adults with gout or CPPD and people with osteoarthritis to see if crystal deposits in joints and blood vessels change over time and relate to treatments or heart problems.

  Recruiting I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio · Milan, Milano · NCT07504146

• Remote monitoring for gout in primary care

  This project will test a smartphone self-management app to help adults with gout and high urate levels manage their condition alongside GP follow-up.

  Recruiting Diakonhjemmet Hospital · Oslo · NCT07490522

• Purified Cortrophin® Gel for treating acute gout flares at two dose levels

  This study will try two single injections (40 U and 80 U) of Purified Cortrophin® Gel to see which dose better and more quickly reduces pain in adults having an acute gout flare.

  Recruiting Phase 4 Massachusetts General Hospital · Boston, Massachusetts · NCT07346079

• IV PRX-115 at different dose schedules, with or without methotrexate, versus placebo for adults with gout

  This trial will test whether IV PRX-115 given on different schedules, with or without low-dose methotrexate, can lower uric acid and be safe in adults whose gout is not controlled by standard urate-lowering drugs.

  Recruiting at 35 sites Phase 2 Protalix · Glendale, Arizona and 34 other locations · NCT07280156

• Dotinurad versus allopurinol for lowering uric acid in gout

  This trial tests whether dotinurad lowers blood uric acid more than allopurinol in adults with gout.

  Recruiting at 103 sites Phase 3 Crystalys Therapeutics · Birmingham, Alabama and 118 other locations · NCT07089875

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.